PCMA President Mark Merritt advocates for greater off-patent drug competition
In response to the U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs" held earlier this month, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt asked policymakers to take an initiative toward making generic drugs easier to produce and distribute. Read More »
Alerts Sign-up